Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as MASLD progression markers. Kim D, Shah M, Kim JH, Kim J, et al. Hepatology 2025;81:962-975.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim D, Shah M, Kim JH, Kim J, et al. Integrative transcriptomic and genomic analyses unveil the IFI16 variants and expression as MASLD progression markers. Hepatology 2025;81:962-975.
PMID: 38385945